Considering the Side Effects of Drugmakers’ Money-Back Guarantees

Monday, July 10, 2017 - 10:52 in Health & Medicine

The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net